Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

International Guillain-Barré Syndrome Outcome Study

ClinicalTrials.gov ID: NCT01582763

Public ClinicalTrials.gov record NCT01582763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS). The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual patients with Guillain-Barré syndrome, as early as possible after onset of disease.

Study identification

NCT ID
NCT01582763
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Erasmus Medical Center
Other
Enrollment
2,000 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2012 (Actual)
Primary completion
Sep 1, 2024 (Actual)
Completion
Dec 2, 2024 (Actual)
Last update posted
Dec 12, 2024

2012 – 2024

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
22
Facility City State ZIP Site status
Barrows Neurological Institute Phoenix Arizona 85013 —
UC Irvine Health Orange California 92868 —
Yale University School of medicine New Haven Connecticut 06520 —
University of Florida Jacksonville Florida 32209 —
Northwestern University Chicago Illinois 60611 —
Southern Illinois University School of Medicine Springfield Illinois 62702 —
University of Iowa Iowa City Iowa 52242-1098 —
University of Kansas Medical Center Kansas City Kansas 66160-7314 —
University of Maryland School of Medicine Baltimore Maryland 21201 —
Johns Hopkins Baltimore Maryland 21205-1911 —
Lahey clinic Boston Boston Massachusetts 01805 —
Tufts University School of Medicine Boston Massachusetts 02135 —
Spectrum Health System Grand Rapids Michigan 49525 —
University of Minnesota Minneapolis Minnesota 55455 —
Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
University of New Mexico Albuquerque New Mexico 87131 —
University at Buffalo Buffalo New York 14203 —
Mt. Sinai School of Med New York New York 10029-6574 —
Columbia University New York New York 10032 —
Montefiore MC New York New York 10467 —
Wexner Medical Center at The Ohio State University Columbus Ohio 43210 —
University of Tennessee Memphis Tennessee 38104 —
UT Southwestern Dallas Texas 75390 —
The university of Texas Health Science Center Houston Texas 77030 —
University of Utah School of Medicine Salt Lake City Utah 84132 —
University of Vermont College of Medicine Burlington Vermont 05405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 112 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01582763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01582763 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →